The overall 5-year survival rate for people with SCLC is 7%. If you have regional stage SCLC, it means your cancer has spread outside your lung to nearby areas. The 5-year survival rate for this ...

Early detection is the key to surviving lung cancer, but Oklahomans rank 44th out of 47 states in early-stage diagnosis ...

A groundbreaking study has revealed a significant link between the frequency of chest X-ray referrals from GPs and earlier diagnosis and improved survival rates for lung cancer patients ... survival ...

Small cell lung cancer, Amgen detailed in the news release, has a 5% to 10% five-year relative survival rate across all stages combined, and comprises approximately 15% of the more than 2.4 million ...

Lung cancer screening with low-dose CT could have saved tens of thousands of lives — if only we'd listened to the data back ...

Only half of study participants continued to get annual lung cancer screenings at least two years after their first.

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients with unresectable, locally advanced, stage III non–small cell lung cancer ...

First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.

Adults who adhered to lung cancer screening had a higher diagnosis rate vs ... 55 to 75 years who had undergone an initial LCS between Jan. 1, 2015, and Dec. 31, 2018, in one of five health ...

Research from the University of Sheffield analyzed records from more than 170,000 lung cancer patients in England between 2014 and 2018, combined with chest X-ray rates from 7,400 GP practices.